News Focus
News Focus
Followers 96
Posts 9220
Boards Moderated 0
Alias Born 02/03/2018

Re: None

Saturday, 05/10/2025 11:31:33 AM

Saturday, May 10, 2025 11:31:33 AM

Post# of 802944
Given the breadth and width of these recent regulatory updates, it would explain why the review has taken longer than expected, BUT for a favorable reason. Regulatory acceptance of DCVAX as a broader cancer treatment platform comes as a surprise development, and more than we could have hoped for.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News